Lilly has reported comprehensive outcomes from the Phase III trial of tirzepatide for individuals with heart failure with ...
Novotech, the global full-service clinical CRO, has published a new report, Small Cell Lung Cancer: Global Clinical Trial ...
USC professor Berislav Zlokovic is on leave after whistleblowers cast doubt on his published work and derailed trials for an ...
Top-line data for its phase 2b trial studying GH001 is expected either in the fourth quarter of 2024 or the first quarter of ...
PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has released its financial results for the third quarter of 2024, ...
Medical researchers at the University of Iowa report promising progress in fighting one of the worst cancer killers. The ...
Amlodipine & perindopril, amlodipine & indapamide, and perindopril & indapamide achieved blood pressure control in 70 percent ...
In its latest earnings report, Cogent Biosciences highlighted ... the company maintains a robust cash reserve and anticipates further clinical trial results in 2025. Looking ahead, Cogent ...
Establishing growing body of preclinical data evaluating the DNase-based oncology platform across a number of high-value ...
Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma ...